Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.

Schulze-Koops, Hendrik; Specker, Christof; Skapenko, Alla

Schulze-Koops, Hendrik; Specker, Christof; Skapenko, Alla.

Affiliation

Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig Maximilians University of Munich, Munich, Germany hendrik.schulze-koops@med.uni-muenchen.de.
Specker C; Klinik für Rheumatologie und Klinische Immunologie, KEM Kliniken Essen-Mitte, Essen, Germany.
Skapenko A; Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig Maximilians University of Munich, Munich, Germany.

RMD Open ; 7(1)2021 02.

Article de En | MEDLINE | ID: mdl-33627439

Sujet(s)
Mots clés

COVID-19; inflammation; vaccination

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rhumatismes / Vaccins contre la COVID-19 / COVID-19 Type d'étude: Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: RMD Open Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google